Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
7 7 Search
2025
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12
Nature Communications
2025
m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability
Nature Communications
2025
The RNA‐Binding Proteins MCPIP2 and IGF2BP1 Competitively Modulate Breast Tumor Angiogenesis by Antagonizing VEGFA mRNA Stability and Expression
The FASEB Journal
2025
Exosome‐Shuttled METTL14 From AML‐Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A‐IGF2BP3‐Dependent Mechanism
Drug Development Research
2024
RNA modification in normal hematopoiesis and hematologic malignancies
MedComm
2024
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade
Annals of Hematology
2024
The m6A reader IGF2BP1 attenuates the stability of RPL36 and cell proliferation to mediate benzene hematotoxicity by recognizing m6A modification
Toxicology